Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3660055

Cc1cc([N+]2(C3CCNC3)CCCC2C)ccc1NC(=O)Nc1cc(Cl)cc(Cl)c1.O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.39
CYP3A4 P08684 1/20 0.39
JAK3 P52333 1/20 0.38
KDR P35968 3/20 0.37
ALOX5 P09917 1/20 0.33
EPHX2 P34913 1/20 0.33
BRAF P15056 2/20 0.32
DHODH Q02127 1/20 0.32
CXCR2 P25025 1/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3661317 0.94 HRH3 (0.43) HRH3CYP3A4JAK3KDRALOX5
Trifluoroacetic Acid SCHEMBL3655804 0.86 CYP1A2 (0.36) KMT2A
Trifluoroacetic Acid SCHEMBL3660920 0.85 HRH3 (0.38) HRH3JAK3
SCHEMBL3658860 0.84 JAK3 (0.43) HRH3JAK3
Trifluoroacetic Acid SCHEMBL3655792 0.80 MAPT (0.37) SMN1; SMN2
Trifluoroacetic Acid SCHEMBL3651075 0.80 CYP1A2 (0.40) CYP3A4MEN1ALDH1A1HTTKMT2A
SCHEMBL3660320 0.79 HRH3 (0.41) HRH3EPHX2MEN1ALDH1A1HTT
SCHEMBL3657582 0.79 HRH3 (0.41) HRH3JAK3MEN1ALDH1A1HTT
Trifluoroacetic Acid SCHEMBL3654963 0.78
Trifluoroacetic Acid SCHEMBL3654252 0.78 FLT3 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2215058-A1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE UREAS AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2010-08-11 EP disclosed
WO-2009052068-A1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE UREAS AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-04-23 WO disclosed